Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement

Journal of Neuroimmunology

Volumn 111, Issue 1-2, 2000, Pages 23-33

  Abdul Majid, Khairul Bariah ^a   Jirholt, Johan ^b   Stadelmann, Christine ^c   Stefferl, Andreas ^c   Kjellén, Peter ^b   Wallström, Erik ^a   Holmdahl, Rikard ^b   Lassmann, Hans ^c   Olsson, Tomas ^a   Harris, Robert A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

EAE; H 2(q), DBA 1; MOG

Indexed keywords

ADJUVANT; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATION; GENOTYPE; HISTOPATHOLOGY; IMMUNIZATION; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; AUTOANTIBODIES; CELL DIVISION; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; EPITOPES, T-LYMPHOCYTE; IMMUNIZATION; IMMUNODOMINANT EPITOPES; LYMPH NODES; MACROPHAGES; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, INBRED DBA; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; SPINAL CORD; SPLEEN; SUPPORT, NON-U.S. GOV'T; VIRULENCE FACTORS, BORDETELLA;

EID: 0034333272     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00360-X     Document Type: Article

References (50)

1. Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein
2. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice
3. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: the protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic Boligomer
4. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
5. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints
6. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)
7. Immunisation against heterologous type II collagen induces arthritis in mice
8. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2
9. Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein I-Au, which confers susceptibility to experimental allergic encephalomyelitis
10. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
11. Identification of autoantibodies associated with myelin damage in multiple sclerosis
12. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
13. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401
14. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
15. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice
16. Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice
17. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis
18. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes
19. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2A(q) and H-2A(p) molecules
20. Importance of CD23 for collagen-induced arthritis: delayed onset and reduced severity in CD23-deficient mice
21. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors
22. Determinant spreading during experimental autoimmune encephalomyelitis: is it potentiating, protecting or participating in the disease?
23. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
24. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
25. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
26. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice
27. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
28. Mice lacking all conventional MHC class II genes
29. Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines
30. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells
31. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice
32. Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant
33. Studies on type II collagen induced arthritis in mice
34. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex
35. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
36. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route
37. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation
38. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study
39. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the 'resistant' Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
40. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination
41. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
42. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6
43. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
44. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
45. The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis
46. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
47. MHC haplotype-dependent regulation of MOG induced EAE in rats
48. Type II collagen-induced arthritis in mice I. Major histocompatibility complex (I region) linkage and antibody correlates
49. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls
50. Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat